跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 470 条关于
“ACE2”
全部
470
临床试验
358
药物
84
机构
7
资讯
21
9个月前
ACE2 Decoy Receptor Shows Promise Against Multiple SARS-CoV-2 Variants in New Study
去年
Machine Learning Identifies Serological Predictors of COVID-19 Outcomes
3个月前
Covid Vaccination Linked to 24% Reduction in All-Cause Cardiac Events in Million-Veteran Study
去年
STORM Therapeutics' NSP14 Inhibitors Show Promise Against Coronaviruses
去年
Azelastine Nasal Spray Shows Promise in Preventing COVID-19 Infections in Clinical Trial
2年前
Invivyd Initiates Phase 1 Trial of VYD2311, a Novel Monoclonal Antibody for COVID-19
去年
FDA Updates Pemgarda EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility Data
去年
Invivyd's Pemgarda Shows Continued Neutralizing Activity Against SARS-CoV-2 Variant XEC
去年
Invivyd Secures $30M Non-dilutive Loan Facility to Advance COVID-19 Antibody Pipeline
去年
Invivyd's PEMGARDA Shows 84% COVID-19 Prevention Efficacy in Landmark Phase 3 Trial
第 1 页,共 3 页
上一页
下一页